UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended March 31, 2023
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period From to
Commission File Number 001-37845
MICROSOFT CORPORATION
Washington
91-1144442
(STATE OF INCORPORATION)
(I.R.S. ID)
ONE MICROSOFT WAY, REDMOND, Washington 98052-6399
(425) 882-8080
www.microsoft.com/investor
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of exchange on which registered
Common stock, $0.00000625 par value per share
MSFT
Nasdaq
3.125% Notes due 2028
MSFT
Nasdaq
2.625% Notes due 2033
MSFT
Nasdaq
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
Accelerated Filer
Non-accelerated Filer
Smaller Reporting Company
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Class
Outstanding as of April 20, 2023
Common Stock, $0.00000625 par value per share
7,435,487,575 shares
MICROSOFT CORPORATION
FORM 10-Q
For the Quarter Ended March 31, 2023
INDEX
Page
PART I.
FINANCIAL INFORMATION
Item 1.
Financial Statements
a)
Income Statements for the Three and Nine Months Ended March 31, 2023 and 2022
b)
Comprehensive Income Statements for the Three and Nine Months Ended March 31, 2023 and 2022
c)
Balance Sheets as of March 31, 2023 and June 30, 2022
d)
Cash Flows Statements for the Three and Nine Months Ended March 31, 2023 and 2022
e)
Stockholders’ Equity Statements for the Three and Nine Months Ended March 31, 2023 and 2022
f)
Notes to Financial Statements
g)
Report of Independent Registered Public Accounting Firm
31
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
32
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
50
Item 4.
Controls and Procedures
50
PART II.
OTHER INFORMATION
Item 1.
Legal Proceedings
51
Item 1A.
Risk Factors
51
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
66
Item 6.
Exhibits
67
SIGNATURE
68
PART I
Item 1
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
INCOME STATEMENTS
(In millions, except per share amounts) (Unaudited)
Three Months Ended
March 31,
Nine Months Ended
March 31,
2023
2022
2023
2022
Revenue:
Product
15,588
17,366
47,846
54,776
Service and other
37,269
31,994
107,880
91,629
Total revenue
52,857
49,360
155,726
146,405
Cost of revenue:
Product
3,941
4,584
13,933
14,707
Service and other
12,187
11,031
35,135
31,514
Total cost of revenue
16,128
15,615
49,068
46,221
Gross margin
36,729
33,745
106,658
100,184
Research and development
6,984
6,306
20,456
17,663
Sales and marketing
5,750
5,595
16,555
15,521
General and administrative
1,643
1,480
5,378
4,151
Operating income
22,352
20,364
64,269
62,849
Other income (expense), net
321
(174
315
380
Income before income taxes
22,673
20,190
64,584
63,229
Provision for income taxes
4,374
3,462
12,304
7,231
Net income
18,299
16,728
52,280
55,998
Earnings per share:
Basic
2.46
2.23
7.02
7.46
Diluted
2.45
2.22
6.99
7.41
Weighted average shares outstanding:
Basic
7,441
7,493
7,450
7,504
Diluted
7,464
7,534
7,474
7,552
Refer to accompanying notes.
PART I
Item 1
COMPREHENSIVE INCOME STATEMENTS
(In millions) (Unaudited)
Three Months Ended
March 31,
Nine Months Ended
March 31,
2023
2022
2023
2022
Net income
18,299
16,728
52,280
55,998
Other comprehensive income (loss), net of tax:
Net change related to derivatives
(9
(34
Net change related to investments
753
(2,882
(796
(4,047
Translation adjustments and other
69
(37
(136
(259
Other comprehensive income (loss)
813
(2,913
(966
(4,298
Comprehensive income
19,112
13,815
51,314
51,700
Refer to accompanying notes.
PART I
Item 1
BALANCE SHEETS
(In millions) (Unaudited)
March 31,
2023
June 30,
2022
Assets
Current assets:
Cash and cash equivalents
26,562
13,931
Short-term investments
77,865
90,826
Total cash, cash equivalents, and short-term investments
104,427
104,757
Accounts receivable, net of allowance for doubtful accounts of $495 and $633
37,420
44,261
Inventories
2,877
3,742
Other current assets
19,165
16,924
Total current assets
163,889
169,684
Property and equipment, net of accumulated depreciation of $65,998 and $59,660
88,132
74,398
Operating lease right-of-use assets
13,879
13,148
Equity investments
9,415
6,891
Goodwill
67,940
67,524
Intangible assets, net
9,879
11,298
Other long-term assets
26,954
21,897
Total assets
380,088
364,840
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable
15,305
19,000
Current portion of long-term debt
6,245
2,749
Accrued compensation
10,411
10,661
Short-term income taxes
4,163
4,067
Short-term unearned revenue
36,903
45,538
Other current liabilities
12,664
13,067
Total current liabilities
85,691
95,082
Long-term debt
41,965
47,032
Long-term income taxes
25,000
26,069
Long-term unearned revenue
2,698
2,870
Deferred income taxes
302
230
Operating lease liabilities
12,312
11,489
Other long-term liabilities
17,437
15,526
Total liabilities
185,405
198,298
Commitments and contingencies
Stockholders’ equity:
Common stock and paid-in capital – shares authorized 24,000; outstanding 7,437 and 7,464
92,093
86,939
Retained earnings
108,234
84,281
Accumulated other comprehensive loss
(5,644
(4,678
Total stockholders’ equity
194,683
166,542
Total liabilities and stockholders’ equity
380,088
364,840
Refer to accompanying notes.
PART I
Item 1
CASH FLOWS STATEMENTS
(In millions) (Unaudited)
Three Months Ended
March 31,
Nine Months Ended
March 31,
2023
2022
2023
2022
Operations
Net income
18,299
16,728
52,280
55,998
Adjustments to reconcile net income to net cash from operations:
Depreciation, amortization, and other
3,549
3,773
9,987
10,481
Stock-based compensation expense
2,465
1,906
7,195
5,505
Net recognized losses (gains) on investments and derivatives
(40
105
152
(566
Deferred income taxes
(1,675
(198
(4,171
(5,985
Changes in operating assets and liabilities:
Accounts receivable
(1,408
857
7,157
5,800
Inventories
106
(279
868
(662
Other current assets
1,152
91
428
1,861
Other long-term assets
(554
(724
(1,285
(2,230
Accounts payable
(407
520
(4,032
284
Unearned revenue
(181
(209
(8,689
(7,437
Income taxes
1,414
1,091
(1,039
1,687
Other current liabilities
1,715
1,287
(490
(1,111
Other long-term liabilities
438
451
781
Net cash from operations
24,441
25,386
58,812
64,406
Financing
Repayments of debt
(4,197
(1,750
(9,023
Common stock issued
536
477
1,354
1,380
Common stock repurchased
(5,509
(8,822
(16,541
(23,939
Common stock cash dividends paid
(5,059
(4,645
(14,746
(13,503
Other, net
(258
(158
(839
(522
Net cash used in financing
(10,290
(17,345
(32,522
(45,607
Investing
Additions to property and equipment
(6,607
(5,340
(19,164
(17,015
Acquisition of companies, net of cash acquired, and purchases of intangible and other assets
(301
(18,719
(1,329
(20,775
Purchases of investments
(9,063
(8,723
(25,675
(21,537
Maturities of investments
13,154
1,099
26,744
15,214
Sales of investments
1,239
16,693
8,725
25,218
Other, net
(1,686
(1,181
(2,847
(1,687
Net cash used in investing
(3,264
(16,171
(13,546
(20,582
Effect of foreign exchange rates on cash and cash equivalents
29
24
(113
57
Net change in cash and cash equivalents
10,916
(8,106
12,631
(1,726
Cash and cash equivalents, beginning of period
15,646
20,604
13,931
14,224
Cash and cash equivalents, end of period
26,562
12,498
26,562
12,498
Refer to accompanying notes.
PART I
Item 1
STOCKHOLDERS’ EQUITY STATEMENTS
(In millions, except per share amounts) (Unaudited)
Three Months Ended
March 31,
Nine Months Ended
March 31,
2023
2022
2023
2022
Common stock and paid-in capital
Balance, beginning of period
90,225
84,528
86,939
83,111
Common stock issued
536
477
1,354
1,380
Common stock repurchased
(1,133
(1,313
(3,394
(4,401
Stock-based compensation expense
2,465
1,906
7,195
5,505
Other, net
169
(1
172
Balance, end of period
92,093
85,767
92,093
85,767
Retained earnings
Balance, beginning of period
99,368
75,045
84,281
57,055
Net income
18,299
16,728
52,280
55,998
Common stock cash dividends
(5,053
(4,634
(15,176
(13,931
Common stock repurchased
(4,380
(7,506
(13,151
(19,489
Balance, end of period
108,234
79,633
108,234
79,633
Accumulated other comprehensive loss
Balance, beginning of period
(6,457
437
(4,678
1,822
Other comprehensive income (loss)
813
(2,913
(966
(4,298
Balance, end of period
(5,644
(2,476
(5,644
(2,476
Total stockholders’ equity
194,683
162,924
194,683
162,924
Cash dividends declared per common share
0.68
0.62
2.04
1.86
Refer to accompanying notes.
PART I
Item 1
NOTES TO FINANCIAL STATEMENTS
(Unaudited)
NOTE 1 — ACCOUNTING POLICIES
Accounting Principles
Our unaudited interim consolidated financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). In the opinion of management, the unaudited interim consolidated financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. Interim results are not necessarily indicative of results for a full year. The information included in this Form 10-Q should be read in conjunction with information included in the Microsoft Corporation fiscal year 2022 Form 10-K filed with the U.S. Securities and Exchange Commission on July 28, 2022.
Principles of Consolidation
The consolidated financial statements include the accounts of Microsoft Corporation and its subsidiaries. Intercompany transactions and balances have been eliminated.
Estimates and Assumptions
Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. Examples of estimates and assumptions include: for revenue recognition, determining the nature and timing of satisfaction of performance obligations, and determining the standalone selling price (“SSP”) of performance obligations, variable consideration, and other obligations such as product returns and refunds; loss contingencies; product warranties; the fair value of and/or potential impairment of goodwill and intangible assets for our reporting units; product life cycles; useful lives of our tangible and intangible assets; allowances for doubtful accounts; the market value of, and demand for, our inventory; stock-based compensation forfeiture rates; when technological feasibility is achieved for our products; the potential outcome of uncertain tax positions that have been recognized in our consolidated financial statements or tax returns; and determining the timing and amount of impairments for investments. Actual results and outcomes may differ from management’s estimates and assumptions due to risks and uncertainties.
In July 2022, we completed an assessment of the useful lives of our server and network equipment. Due to investments in software that increased efficiencies in how we operate our server and network equipment, as well as advances in technology, we determined we should increase the estimated useful lives of both server and network equipment from four years to six years. This change in accounting estimate was effective beginning fiscal year 2023. Based on the carrying amount of server and network equipment included in property and equipment, net as of June 30, 2022, the effect of this change in estimate for the three months ended March 31, 2023 was an increase in operating income of $885 million and net income of $720 million, or $0.10 per both basic and diluted share. The effect of this change for the nine months ended March 31, 2023 was an increase in operating income of $2.9 billion and net income of $2.3 billion, or $0.32 and $0.31 per basic and diluted share, respectively.
Financial Instruments
Investments
We consider all highly liquid interest-earning investments with a maturity of three months or less at the date of purchase to be cash equivalents. The fair values of these investments approximate their carrying values. In general, investments with original maturities of greater than three months and remaining maturities of less than one year are classified as short-term investments. Investments with maturities beyond one year may be classified as short-term based on their highly liquid nature and because such marketable securities represent the investment of cash that is available for current operations.
PART I
Item 1
Debt investments are classified as available-for-sale and realized gains and losses are recorded using the specific identification method. Changes in fair value, excluding credit losses and impairments, are recorded in other comprehensive income. Fair value is calculated based on publicly available market information or other estimates determined by management. If the cost of an investment exceeds its fair value, we evaluate, among other factors, general market conditions, credit quality of debt instrument issuers, and the extent to which the fair value is less than cost. To determine credit losses, we employ a systematic methodology that considers available quantitative and qualitative evidence. In addition, we consider specific adverse conditions related to the financial health of, and business outlook for, the investee. If we have plans to sell the security or it is more likely than not that we will be required to sell the security before recovery, then a decline in fair value below cost is recorded as an impairment charge in other income (expense), net and a new cost basis in the investment is established. If market, industry, and/or investee conditions deteriorate, we may incur future impairments.
Equity investments with readily determinable fair values are measured at fair value. Equity investments without readily determinable fair values are measured using the equity method or measured at cost with adjustments for observable changes in price or impairments (referred to as the measurement alternative). We perform a qualitative assessment on a periodic basis and recognize an impairment if there are sufficient indicators that the fair value of the investment is less than carrying value. Changes in value are recorded in other income (expense), net.
Derivatives
Derivative instruments are recognized as either assets or liabilities and measured at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation.
For derivative instruments designated as fair value hedges, gains and losses are recognized in other income (expense), net with offsetting gains and losses on the hedged items. Gains and losses representing hedge components excluded from the assessment of effectiveness are recognized in other income (expense), net.
For derivative instruments designated as cash flow hedges, gains and losses are initially reported as a component of other comprehensive income and subsequently recognized in other income (expense), net with the corresponding hedged item. Gains and losses representing hedge components excluded from the assessment of effectiveness are recognized in other income (expense), net.
For derivative instruments that are not designated as hedges, gains and losses from changes in fair values are primarily recognized in other income (expense), net.
Fair Value Measurements
We account for certain assets and liabilities at fair value. The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. We categorize each of our fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety. These levels are:
•Level 1 – inputs are based upon unadjusted quoted prices for identical instruments in active markets. Our Level 1 investments include U.S. government securities, common and preferred stock, and mutual funds. Our Level 1 derivative assets and liabilities include those actively traded on exchanges.
PART I
Item 1
•Level 2 – inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques (e.g. the Black-Scholes model) for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs including interest rate curves, credit spreads, foreign exchange rates, and forward and spot prices for currencies. Our Level 2 investments include commercial paper, certificates of deposit, U.S. agency securities, foreign government bonds, mortgage- and asset-backed securities, corporate notes and bonds, and municipal securities. Our Level 2 derivative assets and liabilities include certain cleared swap contracts and over-the-counter forward, option, and swap contracts.
•Level 3 – inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models. Our Level 3 assets and liabilities include investments in corporate notes and bonds, municipal securities, and goodwill and intangible assets, when they are recorded at fair value due to an impairment charge. Unobservable inputs used in the models are significant to the fair values of the assets and liabilities.
We measure equity investments without readily determinable fair values on a nonrecurring basis. The fair values of these investments are determined based on valuation techniques using the best information available, and may include quoted market prices, market comparables, and discounted cash flow projections.
Our other current financial assets and current financial liabilities have fair values that approximate their carrying values.
Contract Balances and Other Receivables
As of March 31, 2023 and June 30, 2022, other receivables due from suppliers were $717 million and $1.0 billion, respectively, and are included in accounts receivable, net in our consolidated balance sheets.
As of March 31, 2023 and June 30, 2022, long-term accounts receivable, net of allowance for doubtful accounts, was $4.3 billion and $3.8 billion, respectively, and is included in other long-term assets in our consolidated balance sheets.
We record financing receivables when we offer certain of our customers the option to acquire our software products and services offerings through a financing program in a limited number of countries. As of March 31, 2023 and June 30, 2022, our financing receivables, net were $2.7 billion and $4.1 billion, respectively, for short-term and long-term financing receivables, which are included in other current assets and other long-term assets in our consolidated balance sheets. We record an allowance to cover expected losses based on troubled accounts, historical experience, and other currently available evidence.
Employee Severance
On January 18, 2023, we announced a decision to reduce our overall workforce by approximately 10,000 jobs through the third quarter of fiscal year 2023. During the three months ended December 31, 2022, we recorded $800 million of employee severance expenses related to these job eliminations as part of an ongoing employee benefit plan. These employee severance expenses were included in general and administrative expenses in our consolidated income statements and allocated to our segments based on relative gross margin. Refer to Note 17 – Segment Information and Geographic Data for further information.
10
PART I
Item 1
NOTE 2 — EARNINGS PER SHARE
Basic earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method. Dilutive potential common shares include outstanding stock options and stock awards.
The components of basic and diluted EPS were as follows:
(In millions, except earnings per share)
Three Months Ended
March 31,
Nine Months Ended
March 31,
2023
2022
2023
2022
Net income available for common shareholders (A)
18,299
16,728
52,280
55,998
Weighted average outstanding shares of common stock (B)
7,441
7,493
7,450
7,504
Dilutive effect of stock-based awards
23
41
24
48
Common stock and common stock equivalents (C)
7,464
7,534
7,474
7,552
Earnings Per Share
Basic (A/B)
2.46
2.23
7.02
7.46
Diluted (A/C)
2.45
2.22
6.99
7.41
Anti-dilutive stock-based awards excluded from the calculations of diluted EPS were immaterial during the periods presented.